Overview
Takafumi Ichikawa practices in Kanagawa, Japan. Ichikawa is rated as an Advanced expert by MediFind in the treatment of Melioidosis. Their top areas of expertise are Muscle Atrophy, Heart Failure, Melioidosis, and Heart Failure with Preserved Ejection Fraction (HFpEF).
Their clinical research consists of co-authoring 101 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Melioidosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Heart FailureIchikawa isAdvanced. Learn about Heart Failure.
- MelioidosisIchikawa isAdvanced. Learn about Melioidosis.
- Muscle AtrophyIchikawa isAdvanced. Learn about Muscle Atrophy.
- Experienced
- Acute Coronary SyndromeIchikawa isExperienced. Learn about Acute Coronary Syndrome.
- Atrial FibrillationIchikawa isExperienced. Learn about Atrial Fibrillation.
- Diabetic NephropathyIchikawa isExperienced. Learn about Diabetic Nephropathy.
- DiarrheaIchikawa isExperienced. Learn about Diarrhea.
- GastritisIchikawa isExperienced. Learn about Gastritis.
- Heart Failure with Preserved Ejection Fraction (HFpEF)